Ecuador vs Togo: Access to anti-retroviral drugs, male
Ecuador
87.0%
in 2024
Togo
86.0%
in 2024
Ecuador rank
27th
Togo rank
30th
Access to anti-retroviral drugs, male over time
- Ecuador
- Togo
How they compare
Ecuador currently reports 87.0% against 86.0% in Togo, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Ecuador ahead.
Ecuador ranks 27th and Togo ranks 30th of 141 countries.
Across the 3 decades both report, Ecuador averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Ecuador | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 6.1% | 0.9% | Togo |
| 2010s | 37.9% | 37.6% | 0.3% | Ecuador |
| 2020s | 79.8% | 74.2% | 5.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ecuador or Togo?
- Ecuador, at 87.0% against 86.0% in Togo as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ecuador and Togo?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Ecuador and Togo rank globally for access to anti-retroviral drugs, male?
- Ecuador ranks 27th and Togo ranks 30th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.